Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia

Arthritis and Rheumatism
W P MaierP M Woodlee

Abstract

Seven patients with thrombocytopenia and systemic lupus erythematosus were treated with intravenous (IV) doses of human immunoglobulin to assess clinical response and to examine the mechanism of action of IV immunoglobulin in these patients. Five of 7 patients had a greater than 50% increase in their platelet counts. Four of these patients had a sustained benefit of at least 6 months duration. The initial effectiveness of IV immunoglobulin therapy was not dependent on the reduction of levels of circulating platelet-binding IgG or circulating immune complexes.

References

Apr 1, 1979·The Journal of Clinical Investigation·J S McDougalC L Christian
Mar 8, 1979·The New England Journal of Medicine·M M FrankP H Plotz
Feb 1, 1977·Annals of Internal Medicine·D R Budman, A D Steinberg
Jan 1, 1986·International Archives of Allergy and Applied Immunology·R Y Lin, S P Racis
Aug 7, 1986·The New England Journal of Medicine·J W NewburgerS P Sanders
Feb 1, 1987·The Journal of Clinical Investigation·D Y LeungR S Geha
Jul 1, 1987·The Journal of Infection·J L LundbladG Mitra
Jul 24, 1987·JAMA : the Journal of the American Medical Association·C M RoifmanE W Gelfand
Aug 1, 1985·British Journal of Haematology·S BallU M Hegde
Jul 16, 1983·Lancet·M AriizumiT Momoki
Feb 1, 1983·British Journal of Haematology·B GrossU E Nydegger
Jun 1, 1984·Blut·G GaedickeD Niethammer
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester

❮ Previous
Next ❯

Citations

Jan 1, 1997·Scandinavian Journal of Rheumatology·E D Silverman, B Lang
Jan 22, 2003·Drugs·Fayez F HejailiWilliam F Clark
Jan 13, 2017·Pediatric Annals·Martha M Rodriguez, Linda Wagner-Weiner
Aug 1, 1993·Journal of Internal Medicine·M Björkholm
Aug 9, 2003·Expert Opinion on Drug Safety·Yaniv ShererYehuda Shoenfeld
Sep 26, 2006·Journal of Neurology·Andreas Steinbrecher, Peter Berlit
Apr 20, 2011·Current Rheumatology Reports·Alana B Levine, Doruk Erkan
Mar 13, 2015·Current Rheumatology Reports·Zehra Serap ArıcıSeza Ozen
Apr 23, 2003·Current Opinion in Rheumatology·Yolanda Braun-Moscovici, Daniel E Furst
May 25, 2004·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Ken YamajiHiroshi Hashimoto
Aug 7, 2009·Autoimmunity·Yoav ArnsonHoward Amital
Sep 9, 2010·Rheumatology·Alastair L HepburnJustin C Mason
Mar 29, 2019·Current Opinion in Rheumatology·Ruba Kado, W Joseph McCune
Nov 8, 2013·The Open Rheumatology Journal·Fozya Bashal
Nov 1, 1991·Clinical and Experimental Immunology·S V KaveriM D Kazatchkine
Dec 1, 1993·Blood Reviews·D M Keeling, D A Isenberg
Dec 21, 2004·Seminars in Arthritis and Rheumatism·Hedi OrbachYehuda Shoenfeld
May 11, 2000·Seminars in Arthritis and Rheumatism·Y LevyY Shoenfeld

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.